|
This is an index of adverse event reports related to Keppra (Levetiracetam). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (496)
Cases resulting in a serious event (494)
Cases resulting in death (45)
Cases resulting in life threatening events (20)
Cases resulting in hospitalization (198)
Cases resulting in disability (18)
Cases resulting in other serious reactions (212)
Below is a sample of adverse event reports reports related to Keppra (Levetiracetam). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 21 year old male receiving Keppra (Levetiracetam)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-10-31
Patient: 21 year old male
Adverse reactions / side effects: Thrombocytopenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Keppra (Levetiracetam)
Adverse event in 21 year old male receiving Keppra (Levetiracetam)
Reported by a pharmacist from United States on 2007-10-31
Patient: 21 year old male, weighing 30.0 kg (66.0 pounds)
Adverse reactions / side effects: Pancreatitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Ativan
Indication: Agitation
Start date: 2007-07-01
Clonidine
Administration route: Topical
Indication: Neuralgia
Start date: 2007-07-24
End date: 2007-08-03
Demerol
Dosage: 25 to 50 mg every two hours
Indication: Pain
Start date: 2007-07-30
End date: 2007-08-03
Diazepam
Indication: Agitation
Start date: 2007-07-01
Fluconazole
Indication: Candidiasis
Start date: 2007-07-29
End date: 2007-08-03
Keppra
Indication: Convulsion
Start date: 2007-07-12
End date: 2007-08-03
Methadone HCL
Administration route: Oral
Indication: Drug Withdrawal Syndrome
Start date: 2007-07-29
End date: 2007-08-03
Methadone HCL
Administration route: Oral
Indication: Pain
Start date: 2007-07-29
End date: 2007-08-03
Nexium
Indication: Reflux Oesophagitis
Start date: 2007-07-29
End date: 2007-08-13
Paxil
Administration route: Oral
Indication: Depression
Start date: 2007-07-25
End date: 2007-08-03
Pepcid
Start date: 2007-07-01
Other drugs received by patient: Chloral Hydrate; Unasyn; Bisacodyl; Diazepam; Dexmedetomidine; Ketamine HCL
Adverse event in 18 year old female receiving Keppra (Levetiracetam)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 18 year old female, weighing 57.0 kg (125.4 pounds)
Adverse reactions / side effects: Pruritus, Streptococcal Bacteraemia, Tachycardia, Pyrexia, Fatigue, Multiple System Atrophy, Musculoskeletal Stiffness, Pneumothorax, Adrenal Insufficiency, Pleural Effusion, Coordination Abnormal, Splenomegaly, Pharyngeal Erythema, Pulmonary Artery Dilatation, Cardiac Failure Congestive, Lung Injury, Hypotension, Pancytopenia, Abnormal Behaviour, Encephalopathy, Rash, Cognitive Disorder, Convulsion, Myoclonus, Irritability, Agranulocytosis, Eye Rolling, Diarrhoea, Sepsis, Ear Pain
Adverse event resulted in: hospitalization
Suspect drug(s):
Augmentin
Start date: 2006-05-01
Depakote
Felbamate
End date: 2006-06-08
Keppra
Dosage: 750 mg, bid
End date: 2006-06-01
Keppra
Dosage: 750 mg, bid
Tegretol
Indication: Epilepsy
Tegretol
Start date: 1992-01-01
End date: 1999-01-01
Tegretol
Start date: 1999-01-01
Topiramate
Adverse event in male receiving Keppra (Levetiracetam)
Reported by a pharmacist from United States on 2007-10-30
Patient: male, weighing 33.4 kg (73.5 pounds)
Adverse reactions / side effects: Blood Amylase Increased, Pancreatitis, Lipase Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Ativan
Dosage: text:3-4.5mg-freq:q3-4h: prn
Indication: Agitation
Start date: 2007-07-06
End date: 2007-08-03
Clonidine
Indication: Neuralgia
Demerol
Dosage: text:25-50 mg-freq:q2h: prn
Indication: Pain
Start date: 2007-07-30
End date: 2007-08-03
Diazepam
Indication: Agitation
Fluconazole
Indication: Systemic Candida
Start date: 2007-07-29
End date: 2007-08-03
Keppra
Indication: Convulsion
Start date: 2007-07-12
End date: 2007-08-03
Methadone HCL
Administration route: Oral
Indication: Pain
Start date: 2007-07-29
End date: 2007-08-03
Methadone HCL
Indication: Sedation
Nexium
Indication: Gastrooesophageal Reflux Disease
Start date: 2007-07-29
End date: 2007-08-03
Paxil
Dosage: daily dose:15mg
Administration route: Oral
Start date: 2007-07-01
End date: 2007-08-03
Adverse event in male receiving Keppra (Levetiracetam)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: male, weighing 108.0 kg (237.6 pounds)
Adverse reactions / side effects: Nightmare, Anticonvulsant Drug Level Abnormal, Disorientation, Stress, Grand MAL Convulsion, Brain Oedema, Brain Neoplasm, Thyroid Neoplasm, Thyroid Function Test Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Chantix
Indication: Smoking Cessation Therapy
Start date: 2007-03-25
End date: 2007-05-06
Keppra
Indication: Convulsion
Start date: 2007-01-01
Other drugs received by patient: Benicar; Vitamin CAP
Adverse event in 27 year old female receiving Keppra (Levetiracetam)
Reported by a physician from United States on 2007-10-29
Patient: 27 year old female
Adverse reactions / side effects: Confusional State, Wrong Technique in Drug Usage Process, Paranoia, Aphasia, Incorrect Dose Administered, Urinary Tract Infection, Abnormal Behaviour, Headache, Aggression, Metrorrhagia, Grand MAL Convulsion, Electroencephalogram Abnormal, Complex Partial Seizures, Pharmaceutical Product Complaint
Suspect drug(s):
Keppra
Dosage: 500 mg 2/d po
Administration route: Oral
Indication: Convulsion
End date: 2007-05-30
Keppra
Dosage: 1000 mg 2/d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-05-30
End date: 2007-06-14
Keppra
Dosage: 1500 mg 2/d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-06-14
End date: 2007-08-15
Keppra
Dosage: 3000 mg 2/d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-08-15
End date: 2007-09-05
Keppra
Dosage: 3500 mg 2/d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-09-05
End date: 2007-09-24
Keppra
Dosage: 5000 mg 2/d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-09-24
Other drugs received by patient: Seroquel; Topamax; Lamictal; Ativan; Ambien CR; Abilify; Lyrica; Prilosec; Maxalt-MLT; Geodon
Adverse event in 27 year old female receiving Keppra (Levetiracetam)
Reported by a physician from United States on 2007-10-29
Patient: 27 year old female
Adverse reactions / side effects: Confusional State, Incorrect Dose Administered, Urinary Tract Infection, Condition Aggravated, Underdose, Headache, Convulsion, Metrorrhagia, Pharmaceutical Product Complaint
Suspect drug(s):
Keppra
Dosage: 500 mg 2/d po
Administration route: Oral
Indication: Convulsion
End date: 2007-05-30
Keppra
Dosage: 1000 mg 2/d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-05-30
End date: 2007-06-14
Keppra
Dosage: 1500 mg 2/d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-06-14
End date: 2007-08-15
Keppra
Dosage: 3000 mg 2/d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-08-15
End date: 2007-09-05
Keppra
Dosage: 3500 mg 2/d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-09-05
End date: 2007-09-24
Keppra
Dosage: 5000 mg 2/d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-09-24
Other drugs received by patient: Seroquel; Topamax; Lamictal; Ativan; Ambein CR; Abilify; Lyrica; Prilosec; Maxalt-MLT; Geodon
Adverse event in male receiving Keppra (Levetiracetam)
Reported by a consumer/non-health professional from United Kingdom on 2007-10-29
Patient: male
Adverse reactions / side effects: Confusional State, Oral Intake Reduced, Vomiting, Nausea, Ataxia, Drug Interaction, Rash, Somnolence, Amnesia, Convulsion, Tremor, Balance Disorder, Anorexia, Coordination Abnormal, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Demeclocycline HCL
Dosage: 150 mg 4/d po
Administration route: Oral
Indication: Blood Sodium Decreased
Start date: 2007-04-01
End date: 2007-07-20
Keppra
Dosage: 1000 mg 2/d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-04-01
End date: 2007-07-20
Keppra
Dosage: 750 mg 1/d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-07-01
Adverse event in 35 year old female receiving Keppra (Levetiracetam)
Reported by a physician from Denmark on 2007-10-26
Patient: 35 year old female, weighing 78.0 kg (171.6 pounds)
Adverse reactions / side effects: Metabolic Acidosis, Laboratory Test Interference, Somnolence, Abdominal Pain Upper, Hepatic Enzyme Increased, Fatigue, Blood Alkaline Phosphatase Abnormal, Fluid Retention
Adverse event resulted in: hospitalization
Suspect drug(s):
Keppra
Indication: Epilepsy
Start date: 2007-02-16
End date: 2007-10-08
Unspecified Medications
Adverse event in 59 year old female receiving Keppra (Levetiracetam)
Reported by a physician from United States on 2007-10-26
Patient: 59 year old female, weighing 88.0 kg (193.6 pounds)
Adverse reactions / side effects: Glioblastoma Multiforme, Lymphopenia, Malignant Neoplasm Progression, Asthenia, Candidiasis, Cushing's Syndrome
Adverse event resulted in: hospitalization
Suspect drug(s):
Bactrim DS
Dosage: tiw;po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Decadron
Dosage: 4 mg;qd;po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Keppra
Dosage: 500 mg;bid;po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Temozolomide
Dosage: 75 mg/m2;qd;po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2007-07-01
End date: 2007-08-01
Temozolomide
Dosage: 75 mg/m2;qd;po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2007-09-27
End date: 2007-10-01
Temozolomide
Adverse event in receiving Keppra (Levetiracetam)
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-25
Patient:
Adverse reactions / side effects: Drug Exposure During Pregnancy, Talipes
Suspect drug(s):
Keppra (Levetiracetam)
Adverse event in 21 year old female receiving Keppra (Levetiracetam)
Reported by a consumer/non-health professional from United States on 2007-10-25
Patient: 21 year old female, weighing 88.6 kg (195.0 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Abortion Induced, Pregnancy
Suspect drug(s):
Keppra (Levetiracetam)
Other drugs received by patient: Ortho TRI-Cyclen; Multi-Vitamin
Adverse event in receiving Keppra (Levetiracetam)
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-25
Patient:
Adverse reactions / side effects: Syndactyly, Drug Exposure During Pregnancy
Suspect drug(s):
Keppra (Levetiracetam)
Adverse event in receiving Keppra (Levetiracetam)
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-25
Patient:
Adverse reactions / side effects: Drug Exposure During Pregnancy, Pilonidal Cyst Congenital
Suspect drug(s):
Keppra (Levetiracetam)
Adverse event in receiving Keppra (Levetiracetam)
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-25
Patient:
Adverse reactions / side effects: Drug Exposure During Pregnancy, Kidney Enlargement, Neonatal Disorder
Suspect drug(s):
Keppra (Levetiracetam)
Adverse event in 37 year old female receiving Keppra (Levetiracetam)
Reported by a physician from United States on 2007-10-25
Patient: 37 year old female
Adverse reactions / side effects: Cytogenetic Abnormality, Conversion Disorder, Uterine Contractions During Pregnancy, Premature Labour, Suicidal Ideation, Drug Exposure During Pregnancy, Breast Engorgement, Foetal Growth Retardation, Foetal Malformation, Amniocentesis Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Keppra (Levetiracetam)
Other drugs received by patient: Prenatal; Folic Acid
Adverse event in receiving Keppra (Levetiracetam)
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-25
Patient:
Adverse reactions / side effects: Drug Exposure During Pregnancy, Talipes
Suspect drug(s):
Keppra (Levetiracetam)
Adverse event in female receiving Keppra (Levetiracetam)
Reported by a physician from France on 2007-10-25
Patient: female
Adverse reactions / side effects: Hypersensitivity, Angioedema, Lymphadenopathy, Urticaria, Disseminated Intravascular Coagulation, Nuclear Magnetic Resonance Imaging Brain Abnormal, Pyrexia, Convulsion, Mucosal Inflammation, Oedema, Platelet Count Decreased, Prothrombin Level Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Depakene
Administration route: Oral
Indication: Epilepsy
Keppra
Administration route: Oral
Indication: Epilepsy
Start date: 2007-10-15
Lamictal
Administration route: Oral
Indication: Epilepsy
Start date: 2007-09-12
End date: 2007-10-15
Adverse event in receiving Keppra (Levetiracetam)
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-25
Patient:
Adverse reactions / side effects: Drug Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Suspect drug(s):
Keppra (Levetiracetam)
Adverse event in 7 year old female receiving Keppra (Levetiracetam)
Reported by a physician from United Kingdom on 2007-10-25
Patient: 7 year old female, weighing 26.9 kg (59.2 pounds)
Adverse reactions / side effects: Agitation, Muscle Twitching, Somnolence, Aggression, Anxiety, Affect Lability, TIC, Tearfulness, Eye Disorder
Adverse event resulted in: disablity
Suspect drug(s):
Keppra
Dosage: 700 mg 2/d po
Administration route: Oral
Indication: Partial Seizures
Start date: 2006-12-14
End date: 2007-01-01
Keppra
Dosage: 600 mg 2/d po
Administration route: Oral
Indication: Partial Seizures
Start date: 2007-01-01
Other drugs received by patient: Valproate Sodium
Adverse event in female receiving Keppra (Levetiracetam)
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-25
Patient: female
Adverse reactions / side effects: Drug Exposure During Pregnancy, Abortion Spontaneous
Suspect drug(s):
Keppra (Levetiracetam)
Adverse event in receiving Keppra (Levetiracetam)
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-25
Patient:
Adverse reactions / side effects: Drug Exposure During Pregnancy, HIP Dysplasia
Suspect drug(s):
Keppra (Levetiracetam)
Adverse event in female receiving Keppra (Levetiracetam)
Reported by a individual with unspecified qualification from Germany on 2007-10-25
Patient: female
Adverse reactions / side effects: Drug Exposure During Pregnancy, Pregnancy
Suspect drug(s):
Keppra
Dosage: 1500 mg 2/d
Keppra
Dosage: 1000 mg 2/d
Adverse event in receiving Keppra (Levetiracetam)
Reported by a individual with unspecified qualification from United States on 2007-10-24
Patient:
Adverse reactions / side effects: Renal Impairment, Status Epilepticus
Suspect drug(s):
Keppra (Levetiracetam)
Adverse event in female receiving Keppra (Levetiracetam)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: female, weighing 70.8 kg (155.8 pounds)
Adverse reactions / side effects: Pruritus, Vulvovaginal Burning Sensation, Headache, Convulsion, Suicidal Ideation, Fatigue, Hot Flush, Alopecia, Uterine Leiomyoma, Dizziness, Formication, Depression, Asthenia, Multiple Sclerosis
Suspect drug(s):
Keppra
Indication: Fibromyalgia
Start date: 2007-08-01
End date: 2007-09-18
Lyrica
Administration route: Oral
Indication: Fibromyalgia
Start date: 2007-07-01
End date: 2007-08-01
Other drugs received by patient: Zocor; Ambien
|
